chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received her 1st dose of the Pfizer Covid vaccine around 11:20am, and started feeling bad within about 5-7 minutes of administration.  Her grandmother came to the counter to alert me that she wasn't feeling well, patient was lightheaded and just "felt bad".  She did say she was nauseous, but was very agitated and had trouble verbalizing what was wrong.  She was very hot and clammy, her mother reported that she looked very pale.  I went to get a cuff to take her blood pressure, but by the time I got it on her arm, she was slumping significantly in the chair, so we decided to move her back to the clinic room to lay her down and elevate her feet.  Her mother and I each took an arm to move her.  I thought she may have briefly lost consciousness, her legs were not holding any of her weight, but her head was down, so I couldn't tell if she was alert.  We moved her a few more feet into the room and her mother moved to set her down in a chair, she was talking and alert.  At this time, her bladder evacuated and she vomited, her mom moved her the rest of the way to the chair. I immediately went back to the room with them and dialed 911 at 11:34am.  She was more alert at this time, did not report any difficulty breathing or any swelling or itching of the mouth or throat.  She was very anxious/agitated, but she did say that she felt a little better after vomiting.   EMS arrived at 11:52, I believe she vomited again before they got here, she did take a few sips of water.  EMS left at 12:06pm, the patient and her mother left at 12:07, she was walking on her own, with support from mom.
Patient presented at a vaccine clinic and was due for COVID-19 vaccine.  Onsite staff administered Moderna 0.25mL.  Moderna is only approved for persons 18 years and older for booster.  Patient had not adverse reaction as a result of this incident.
Injection given on 7/25/16 -Called and reported area at site was hard, red, warm to touch and painful.
pt recv vax;had 3 hr of high pitched crying, started 5-6 hr crying;T 101 5 hr p/ shot;
Thursday 05/15/2003 given immunization 2 days later developed hard area on left thigh with tenderness and redness. Increase fussiness. Came to clinic today for evaluation 05/23/2003. Mild myositis vs ematoma from immunization ice and Tylenol rec water for atrophy of muscle or fat.
Patient contacted our office on 3/21/19 to let us know her left arm was hot, red and swollen to the elbow. Patient was directed to UC for assessment. Dx with cellulitis and given one dose of IV antibiotic in clinic and discharged with prescription of oral antibiotic.
On 1/31/2000 in the evening the pt complained of itching to legs by the AM. Pt was covered with hives all over legs and face. Treatment was Benadryl every 4 - 6 hours as needed.
Chills, rash on the chest and side of breast area, no pain or itchiness.
Initial and follow up information has been received from the nursing staff and practice manager of a pediatric practice concerning patients who were vaccinated with a dose of Gardasil and experienced injection site pain routinely when the Gardasil was given. The number of patients experiencing the injection site pain was unreported, and it was unknown if medical attention was sought. The outcome was unknown. The reporter reported that one other pediatric office and another physician reported patient experiencing pain after receiving the Gardasil. In follow up it was indicated by the practice manager that the pain was a generalization that the girls were reporting a tenderness after the shot of Gardasil, but they were coming back for the second and third dose. Additional information has been requested.
headache, severe back muscle aches, fatigue, sinus congestion, cough, no appetite  took Acetaminophen  X2 every four hours or so   symptoms gone after 36 hrs
After administration of vaccine #4, client became limp and lost consciousness. Client immediately began having an upper body seizure, lasting 5-7 seconds, client then became alert for approximately 5 seconds, then had another seizure lasting 5-7 seconds. Client was then alert, but pale and diaphoretic. 911 was called and client was transported to the hospital via ambulance.
Grave's disease; tachycardia; This is a spontaneous report from a contactable consumer (Patient's grandfather) via Pfizer sponsored program. A 15-years-old female patient (Reporter's granddaughter) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 15May2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced Grave's disease and tachycardia. He called in because he heard or saw somewhere regarding the myocarditis side effect of the vaccine. With that, wanted to know if could take the second dose of the vaccine due tomorrow. The outcome of the events was unknown.   Information of lot/batch number has been requested.
Information has been received form a LVN concerning "other patients" who on unspecified dates were vaccinated with one dose of varicella virus vaccine live. Subsequently, the patients developed breakthrough varicella years after vaccination. The patients sought unspecified medical attention. Also reported were other patients who experienced similar events. Additional information has been requested.
I had some issue with my arm/ having difficulty with my arm; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: FA6780 and expiration date was not reported), second dose via an unspecified route of administration on 17Jul2021 as single for covid-19 immunisation and Prednisone route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. Medical history included limb deformity from an unknown date and unknown if ongoing (patient stated I had some issue with my arm and not because of the vaccination and it was prior to that and I have spoken to the doctor and she wanted to put me on steroids a prednisone, will that have any effect on the vaccination). The patient's concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number and expiration date was not reported), first dose via an unspecified route of administration on unspecified date as single for covid-19 immunisation. On an unspecified date the patient experienced some issue with arm/ having difficulty with arm. Patient further stated "No it's not concern about vaccination. It's concerning a thought in around about the way. I want to know if it's going to make the vaccination ineffective or last effective by taking the steroids. It was on the steroids sheet that it says somewhere about vaccination, after getting any vaccination or some vaccination with this drug they either raise a chance of infection or make the vaccine not work as well. So, I don't know if there is a possibility of a side effect and if something I don't need to worry about or not need to worry about." The outcome of the event was unknown.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected
Got the flu; Initial information received on 22-Oct-2021 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional via social media. This case involves adult male patient who had got the flu (Influenza) after receiving INFLUENZA VACCINE.  The patient past vaccination(s) included INFLUENZA VACCINE for prophylactic vaccination.  The patient medical treatment, family history and concomitant medication were not provided.   It was unknown if the patient had any medical history, concomitant disease or risk factor  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported, frequency: not provided] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a serious got the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for this event.(duration: 4 days)  It was unknown if the patient experienced any additional symptoms/events  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.; Sender's Comments: This case involves an adult male patient who presented with Influenza after the vaccination with INFLUENZA VACCINE (unknown manufacturer).Time of onset is unknown. The patient was hospitalized for this influenza event. Further information regarding medical condition during vaccination, previous vaccination and tolerance, other laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
a patient was administered 2nd dose of moderna vaccine on the 16th day after the 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient was administered 2nd dose of moderna vaccine on the 16th day after the 1st dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 022B21A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included GABAPENTIN, ATORVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HYDROCHLOROTHIAZIDE), AMLODIPINE, CLOPIDOGREL BISULFATE (PLAVIX) and EMPAGLIFLOZIN (JARDIANCE) for an unknown indication.   On 09-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient was administered 2nd dose of moderna vaccine on the 16th day after the 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient was administered 2nd dose of moderna vaccine on the 16th day after the 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The caller stated that their computer system did not block from giving the 2nd dose to the patient and she wants to know what she needs to do now and requesting the information to be sent via email.
Developed approx. 3cm rash on 1/28 at the site, then the rash spread locally. Still has rash at the time of reporting on 2/1/20. No other systemic symptoms.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On an unspecified date the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. The patient was treated at a hospital for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of these malfunctions, the patient suffered  painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Pt received vaccine at 8:39 AM. Pt states she begins to feel anxious and also notices her heart rate to be 120 in her watch. Pt is monitored in the recovery area located inside.  VS at 8:52 are HR 99, O2 98%, BP 140/85. Pt states she did not take her blood pressure medications in the morning. At 9:01 her heart rate is 88. At 9:06 BP is 140/80 and HR is 80. Pt is calm and states she feels better and is okay to drive home.
Ive always had a resting heart rate in the upper 70?s innthe past years until the vaccine.  I have noticed that its been staying in upper 90?s  to 103 most of the time especially when I stand up or simply walk across the room.  I didn?t realize what was going on for sure for two or three days.  This on top of being winded easily.
MOM STATED THAT CLIENT STARTED FEELING NAUSEATED ON 11/1. THE NEXT DAY, CLIENT STARTED HAVING A HEADACHE AND STARTED VOMITING. BY 11/3 CLIENT HAD A FEVER OF "102F OR HIGHER", FELT "FREEZING COLD" AND MOM STATES SHE "WAS BURNING UP." MOM STATED CLIENT DEVELOPED WELTS AND HIVES ON 11/3. MOM STATED CLIENT HAD A RAISED WELT FROM WRIST TO ELBOW NO HER LEFT ARM. WELT WAS 2 TO 2.5 INCHES WIDE AND 1/8 INCH RAISED. MOM STATED CLIENT HAD SMALL WELTS FROM SHOULDER TO ELBOW. MOM STATED CLIENT HAD HIVES AROUND THE WELTS AND "HIVES AND RED BLOTCHES" ON HER CHEST AND SHOULDERS. MOM STATED CLIENT "HAD A HARD TIME BREATHING" AND HAD A "SHARP PAIN IN HER CHEST AND RIBCAGE." ON 11/3 CLIENT WAS TAKEN TO THE ER WHERE SHE WAS GIVEN BENADRYL, ICE PACKS, IBUPROFEN, AND "NAUSEA PILLS." MOM WAS INSTRUCTED TO RETURN IF CLIENT GOT WORSE.
Patient presented to Employee Health with R-side facial swelling, VSS BP 120/80, HR 88, Resp 18, Temp 99.5.  Speech clear, denied headache, dizziness, fever chills, no signs of respiratory distress.  Referred to PCP for follow-up.  Employee states today sytoms resolved within one hour after being seen.  Reported to work today with no complaints.
Information has been received from a physician concerning a teenager female who was vaccinated with the first dose of GARDASIL. The patient experienced dizziness after vaccination. Subsequently, the patient recovered from dizziness. The patient sought medical attention.
Suddenly, my heart was pounding and I had a resting heartrate of 120 BPM.  I was short of breath and dizzy and felt that I was on the verge of passing out.  I was at work at the time and an ambulance was called.  The paramedics stated my blood pressure was low.  I declined to be transported to the hospital.  Prior to my second dose I was physically active and was a runner.  During the week after my second dose I noticed that minimal physical activity will cause me to feel out of breath.  I live on the second floor of my apartment and just going down the stairs to throw out the trash and walking back up will cause me to feel out of breath.  I have also started to wheeze while taking deep breaths and while laughing.  These symptoms have been ongoing for a year now and have not subsided.
10 hours after vaccination, began fever, sweating, muscle aches and cramping, chills, and vomiting. 30 hours after vaccine lips swelled and began experiencing angioedema and anaphylaxis.
This spontaneous report as received from a medical assistant refers to a patient or patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On an unknown date in June 2016 (reported as on unspecified dates since last week), the patient or patients were vaccinated with two doses of improperly stored VAQTA lot # M009377, expiration date 17-JUN-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccine experienced the temperature excursion of 33.5 degrees Fahrenheit for 28 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
a delay in my period; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep1533) via an unspecified route of administration in the arm right on 11Apr2021 at 11:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient previously took BONADOXINA. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On unknown date after first dose, patient experienced delayed period. Therapeutic measures were unknown as a result of the event. The clinical outcome of event delayed period was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Acute appendicitis began with abdominal pain, vomiting on 2/3/21,  surgery on 2/5/21. Confirmee by CT scan and operative procedure.
Red blotchy spot on her injection site; Itchy at injection site/rash on her arms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red blotchy spot on her injection site) and VACCINATION SITE PRURITUS (Itchy at injection site/rash on her arms) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red blotchy spot on her injection site) and VACCINATION SITE PRURITUS (Itchy at injection site/rash on her arms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (Red blotchy spot on her injection site) and VACCINATION SITE PRURITUS (Itchy at injection site/rash on her arms) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided.  The patient had received second dose of Moderna vaccine on 26-Feb-2021 and the batch number was reported as 010A21A.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up information received on 27-MAY-2021 contains information regarding reporter contact details. On 02-Jun-2021: Follow-up information received on 02-Jun-2021 contains information regarding second dose of Moderna vaccine.
Large local reaction 10X18 cm around injection site.  Area is red + indurated + warm to touch
TDAP given instead of TD at community health fair. Patient reported on 4-26-2010 that he had no adverse reaction to shot at all. He stated that his arm was not sore or swollen at all.
Patient had no adverse reaction.  Patient received a dose of Pfizer vaccine 03/11/21 at an alternate location.
This spontaneous report as received from a consumer concerning her 4 year old son with eczema and other food allergies and no drug reactions/allergies who on 05-APR-2005 was vaccinated with the first dose of M-M-R II (dose, route and lot # not provided), on 10-JAN-2007 was vaccinated with the second dose of M-M-R II (dose, route and lot # not provided) and on 17-JUN-2009 receive the third dose of M-M-R II (dose, route and lot # not provided). No other co-suspects were reported. No concomitant medications were reported. . It was reported that prior to receiving the third dose (date not provided), the patient had a slight reaction after eating anything that contained egg. On 18-JUN-2009 "24 hours after the third vaccination with M-M-R II)", the patient's whole body from head to toe was itching "inside and out" as the patient put it. The patient would have an itch, but after the third vaccination he was having more serious reactions like an itching in the throat. The patient's mother stated that there was a mix up as he was given 3 not 2 vaccinations and it was after the third one that her son began to experience the more severe reactions. No treatment was given for the events. No laboratory tests were performed. At the time of the report, the patient was recovering from the events. The relatedness for the events was unknown for M-M-R II). Additional information has been requested.
Medical assistant calling to report a temperature excursion that occurred 8/14/2020 which involved the following products: GARDASIL9, PEDVAXHIB, RECOMBIVAX, ROTATEQ. Per caller, "it would be possible that at least 100 patients have received vaccines; This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies or concomitant medications were not reported.  On 04-SEP-2020, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 ml as prophylaxis (lot # S036821 with expiration date 21-APR-2022) (strength, frequency, route of administration and anatomical location were not reported).  The improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced a temperature excursion of 35.4 Fahrenheit degrees (°F) for the time frame of 20 minutes without previous temperature excursions. It was confirmed that a digital data logger was involved.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2009USA006106:
Left axillary tenderness, onset 24 hours after injection, persisting now for 3 days.
In the last 48 hours, have you had a fever* OR symptoms that are unrelated to a preexisting illness?: New muscle aches, New loss of smell
miscarriage; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733), via an unspecified route of administration, administered in right arm on 27Mar2021 at 15:00 (at the age of 42-years-old) as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history and concomitant medications were not reported. The patient had a missed miscarriage on 20Apr2021 at 14:00. The mother reported she became pregnant while taking bnt162b2.  The mother was 10 weeks pregnant at the onset of the event.  The mother was due to deliver on 10Nov2021.  The pregnancy resulted in spontaneous abortion. The event resulted in Emergency room/department or urgent care and was treated with pain medication. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, she has not been tested for COVID-19. The event was resolved.
Moments after the vaccine my arm and hands started tingling and becoming numb in various spots which continued all over my entire face.  I was monitored and was given a shot of benedryl and was sent home after a while.   The next day I felt really groggy, latargic and had diarreah.  That monday the numbness went up to my ear and I reached out to my PCP who prescribed a steroid.   Later that evening I got a really bad headache and the tingling and numbness hit my feet then went up my legs, my arms and up and down my body.  Its a feeling as if my body has fallen asleep.
pt recvd vax; 1 wk later, devel bilateral inguinal lymphadenopathy;